| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70dd1401db4f73425e4a228b71e7294b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0b9d43d8ee8f19d793d049297fcca1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8768ee1d744544fb91a2ecbb54e80fb3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-894
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
| filingDate |
2007-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22032e9d4bc645b5e690caaf55a2ecc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e606337bd508e2f589e215071984ad |
| publicationDate |
2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9107941-B2 |
| titleOfInvention |
Methods and compositions for reducing L-pipecolic acid effects in animals |
| abstract |
The present invention relates to methods and compositions for reducing L-pipecolic acid concentrations and/or effects in animals. In an embodiment, the invention includes a method of reducing plasma concentrations of L-pipecolic acid in animals including administering an effective amount of a composition including saponins. In an embodiment, the invention includes a method of reducing anorectic effects of L-pipecolic acid in animals including administering an effective amount of a composition including saponins. Other embodiments are also included herein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849976-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11006654-B2 |
| priorityDate |
2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |